Mark Strobeck - 14 Mar 2025 Form 4 Insider Report for ROCKWELL MEDICAL, INC. (RMTI)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 Mar 2025, 18:13:48 UTC
Prior SEC filing
06 Jan 2025
Next SEC filing
02 Apr 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Megan Timmins, Attorney-in-Fact for Mark Strobeck

Key filing fact

Mark Strobeck filed Form 4 for ROCKWELL MEDICAL, INC. (RMTI) on 18 Mar 2025.

Key facts

  • This page summarizes Mark Strobeck's Form 4 filing for ROCKWELL MEDICAL, INC. (RMTI).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 18 Mar 2025, 18:13.

Change

  • Previous filing in this sequence was filed on 06 Jan 2025.
  • Current net transaction value: -$23,265.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RMTI transaction

Common Stock

Tax liability

Transaction value
$12,466
Shares
-7,333
Change %
-5.1%
Price
$1.70
Shares after
137,705
Date
14 Mar 2025
Ownership
Direct
Footnotes
F1
RMTI transaction

Common Stock

Tax liability

Transaction value
$10,799
Shares
-6,101
Change %
-4.4%
Price
$1.77
Shares after
131,604
Date
17 Mar 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares were withheld from the vesting of restricted stock units to cover the estimated tax withholding obligation.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .